[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, CEO, Co-Founder, Director and >10% owner of Atlassian Corporation (TEAM), reported multiple open-market sales of Class A common stock on 09/04/2025 executed pursuant to a Rule 10b5-1 trading plan adopted on 02/20/2025. The Form 4 lists five separate sale line items totaling 7,665 shares sold at weighted-average prices ranging from about $167.10 to $169.90. After the reported transactions the filing shows beneficial ownership falling to 137,970 shares held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. The reporting attorney-in-fact signed the form on 09/05/2025. The filer states willingness to provide detailed trade-level information upon request.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions.
- Detailed price ranges and weighted-average prices are disclosed and the filer offers to provide full trade-level information upon request.
- Form 4 signed and filed promptly (signature dated 09/05/2025), showing regulatory compliance.
Negative
- Insider sold 7,665 Class A shares on 09/04/2025, reducing beneficial ownership to 137,970 shares held indirectly.
- Reporting person is a >10% owner; insider sales may be material to perceptions of insider alignment even if executed under a 10b5-1 plan.
Insights
TL;DR: Routine insider disposition under a pre-established 10b5-1 plan; reduces holdings but follows an adopted trading plan.
The Form 4 documents five sale transactions executed on 09/04/2025 under a Rule 10b5-1 plan adopted 02/20/2025. Total reported disposals equal 7,665 Class A shares across multiple trades at weighted-average prices reported per line between approximately $167 and $169.90. Post-transaction beneficial ownership is reported as 137,970 shares held indirectly. This filing conveys compliance with Section 16 reporting and an explicit 10b5-1 defense; no derivative transactions or other compensatory events are disclosed.
TL;DR: Disclosure is consistent and specific; sales are tied to a documented 10b5-1 plan and include undertakings to provide trade details.
The report identifies the reporting person as a CEO, director and >10% owner and specifies that transactions were effected pursuant to a 10b5-1 trading plan. The filing provides weighted-average prices and explains the intraday price ranges for each line item, plus an explicit willingness to supply full trade-level details on request. The signature by an attorney-in-fact is included, and no amendments or derivative positions are reported. Material governance points are disclosure completeness and plan adherence; the filing does not state motives or other corporate actions.